Business

Cannabis investments blazing in Brazil

cannabis investments
Image: iQoncept/Shutterstock

The use of cannabis for recreational purposes remains taboo in Brazil, with the majority of the population still against legalizing the drug. However, regulators are slowly changing the landscape of medical marijuana. A ruling from Brazil’s Sanitary Surveillance Agency (Anvisa) allows companies to produce and sell cannabis-based medications, including in pharmacies. Growing cannabis remains off-limits, however, forcing companies to import the plant extract, requiring high investments and favoring Big Pharma.

But regardless of its limitations, this new ruling should further boost investments in the cannabis market—which have silently been creeping up in recent months. Since October, Brazilian asset...

Access all of The Brazilian Report

Less expensive than a coffee!

Enjoy your 30-day limited-time offer for US$ 0.25 a week